{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:03:13Z","timestamp":1783476193631,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011218","name":"Sandoz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ando.2020.03.005","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T11:28:47Z","timestamp":1583321327000},"page":"210-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The heart in growth hormone (GH) deficiency and the cardiovascular effects of GH"],"prefix":"10.1016","volume":"82","author":[{"given":"Philippe","family":"Chanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2020.03.005_bib0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12020-014-0327-6","article-title":"GH and the cardiovascular system: an update on a topic at heart","volume":"48","author":"Isgaard","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2020.03.005_bib0215","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1056\/NEJMra1817346","article-title":"Pathogenesis and diagnosis of growth hormone deficiency in adults","volume":"380","author":"Melmed","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2020.03.005_bib0220","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/er.2013-1071","article-title":"Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications","volume":"35","author":"Kamenicky","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2020.03.005_bib0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/er.16.1.63","article-title":"Clinical aspects of growth hormone in adults","volume":"16","author":"De Boer","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2020.03.005_bib0230","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The Metabolic Syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2020.03.005_bib0235","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/jc.2009-1326","article-title":"Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement","volume":"95","author":"Attanasio","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0240","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1530\/EJE-06-0699","article-title":"The prevalence of the metabolic syndrome is increased in patients with GH deficiency, irrespective of long-term substitution with recombinant human GH","volume":"156","author":"van der Klaauw","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2020.03.005_bib0245","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Gr*oup","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2020.03.005_bib0250","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2020.03.005_bib0255","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1210\/jc.2014-3787","article-title":"Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies","volume":"100","author":"Pappachan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0260","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1210\/jc.2007-0458","article-title":"Non-fatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone","volume":"92","author":"Holmer","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0265","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1210\/jc.2003-031601","article-title":"Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy","volume":"89","author":"Svensson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0270","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1172\/JCI119095","article-title":"Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double- blind, placebo-controlled study","volume":"98","author":"Boger","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ando.2020.03.005_bib0275","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","article-title":"Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee","volume":"83","author":"Carroll","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0280","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1043-2760(00)00267-8","article-title":"Growth hormone therapy for hypopitutary adults: time for re-appraisal","volume":"11","author":"Barkan","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0285","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1210\/jc.2013-2394","article-title":"Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH\u2013an update","volume":"99","author":"Gazzaruso","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0290","first-page":"309","article-title":"Treatment of adults with growth hormone (GH) deficiency with recombinant human GH","volume":"76","author":"Bengtsson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0295","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2265.2001.01218.x","article-title":"Growth hormone and the heart","volume":"54","author":"Colao","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2020.03.005_bib0300","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1210\/jc.2004-1042","article-title":"The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study","volume":"89","author":"Colao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0305","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s12020-016-1067-6","article-title":"Characterisation of myocardial structure and function in adult-onset growth hormone deficiency using cardiac magnetic resonance","volume":"54","author":"Thomas","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2020.03.005_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-010-0250-7","article-title":"Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study","volume":"14","author":"Andreassen","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2020.03.005_bib0315","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ghir.2019.06.003","article-title":"Short-term evaluation of cardiac morphology, function, metabolism and structure following diagnosis of adult-onset growth hormone deficiency","volume":"46-47","author":"De Cobelli","year":"2019","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.ando.2020.03.005_bib0320","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/edrv.19.2.0329","article-title":"The diagnosis of growth hormone deficiency in children and adults","volume":"19","author":"Shalet","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2020.03.005_bib0325","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM199910143411607","article-title":"Growth hormone therapy in adults and children","volume":"341","author":"Vance","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ando.2020.03.005_bib0330","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.coph.2003.07.008","article-title":"Adult growth hormone replacement: current understanding","volume":"3","author":"Murray","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.ando.2020.03.005_bib0335","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.med.54.101601.152147","article-title":"Growth hormone therapy in adults","volume":"54","author":"Cummings","year":"2003","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ando.2020.03.005_bib0340","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1161\/01.CIR.0000100720.01867.1D","article-title":"Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis","volume":"108","author":"Maison","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2020.03.005_bib0345","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","article-title":"Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a meta-analysis of blinded, randomised, placebo-controlled trials","volume":"89","author":"Maison","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0350","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2265.2004.01935.x","article-title":"Growth hormone replacement in adults and bone mineral density: a systematic review and meta-analysis","volume":"60","author":"Davidson","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2020.03.005_bib0355","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1210\/er.2004-0022","article-title":"The influence of growth hormone status on physical impairments, functional limitations and health-related quality of life in adults","volume":"27","author":"Woodhouse","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2020.03.005_bib0360","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0365","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/EJE-11-0558","article-title":"Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis","volume":"166","author":"Hazem","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2020.03.005_bib0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12477","article-title":"Efficacy and safety of growth hormone treatment in adults with growth hormone deficiency: a systematic review of studies on morbidity","volume":"81","author":"van Bunderen","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2020.03.005_bib0375","first-page":"82","article-title":"Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group","volume":"82","author":"Attanasio","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0380","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/EJE-19-0132","article-title":"Long-term growth hormone (GH) replacement of adult GH deficiency (GHD) benefits the heart","volume":"181","author":"Ziagaki","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2020.03.005_bib0385","first-page":"453","article-title":"Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults","volume":"84","author":"Pfeifer","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0390","first-page":"1329","article-title":"Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency","volume":"84","author":"Borson-Chazot","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0395","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1210\/jc.2009-0806","article-title":"Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma","volume":"95","author":"Webb","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0400","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1530\/EJE-11-1028","article-title":"Overall and cause-specific mortality in GH-deficient adults on GH replacement","volume":"166","author":"Gaillard","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2020.03.005_bib0405","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1210\/jc.2011-1215","article-title":"Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in adults","volume":"96","author":"van Bunderen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.03.005_bib0410","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1210\/jc.2014-1814","article-title":"Socioeconomic factors do not but GH treatment does affect mortality in adult-onset growth hormone deficiency","volume":"99","author":"Stochholm","year":"2014","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426620300408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426620300408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:25:19Z","timestamp":1762086319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426620300408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":41,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0003426620300408"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2020.03.005","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The heart in growth hormone (GH) deficiency and the cardiovascular effects of GH","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2020.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}